-

EBA 2026 Work Programme for a More Efficient EU Regulatory and Supervisory Framework
The European Banking Authority (EBA) has published its 2026 work programme, setting out its key priorities and planned initiatives. The programme is driven by three overarching priorities: (i) developing a rulebook to foster a resilient and efficient financial single market, with proposals to simplify rules, improve public sector coordination and assess the framework’s impact….By: A&O…
-

UK FCA Research Note on Potential Quantum Computing Applications in UK Financial Services
The UK Financial Conduct Authority (FCA) has published a research note examining the potential applications of quantum computing within UK financial services, and exploring how firms can prepare for their emergence….By: A&O Shearman
-

California Transparency in Frontier AI Act Signed Into Law
California enacts first-in-the-nation law focused on regulating frontier artificial intelligence models. On September 29, 2025, California Governor Gavin Newsom signed SB 53 — the Transparency in Frontier Artificial Intelligence Act (TFAIA) — into law. As explained in the Senate floor analysis, the law “requires large artificial intelligence (AI) developers . . . to publish safety…
-

California Sets 30 Day Deadline for Data Breach Notifications
Governor Gavin Newsom recently signed SB 446 into law, introducing significant changes to California’s data breach notification requirements. The bill establishes deadlines for notifying consumers and the state’s Attorney General when personal information of California residents has been involved in a data breach….By: Jackson Lewis P.C.
-

CMS Issues Final Guidance on IPAY 2028 Drug Price Negotiation Program, 2026-28 MFP Effectuation
On September 30, 2025, the Centers for Medicare & Medicaid Services (CMS) issued final guidance (Final Guidance) for initial price applicability year (IPAY) 2028 of the Inflation Reduction Act (IRA) Drug Price Negotiation Program (DPNP). The Final Guidance also implements polices for effectuation of the Maximum Fair Price (MFP) for IPAYs 2026 through 2028….By: Hogan…
-

Ozempic Lawsuit: Litigation Update, Settlement Information, and Taking Action
Many people who have taken Ozempic for weight loss are now taking legal action against the popular GLP-1 drug’s manufacturer. In numerous Ozempic lawsuits filed to date, plaintiffs allege that Novo Nordisk failed to adequately warn consumers of the risks associated with the weight loss drug—including risks for persistent vomiting, bowel obstruction, stomach paralysis, and…
-

The Impact of Vocational Experts in Injury-Related Litigation
When a serious injury disrupts someone’s ability to work and earn money, the ripple effects are immediate and far-reaching. Questions about employability, lost wages, and future earning capacity can quickly become central to litigation. That is where vocational experts step in….By: IMS Legal Strategies
-

Determining Who’s at Fault for Medication Errors
When doctors prescribe medication for us, we expect it to help in some way. We might hope that it will cure a condition or help minimize problems like pain. At the very least, we would expect it to keep things from getting worse….By: Searcy Denney Scarola Barnhart & Shipley
-

Dupixent Lawsuits for T-Cell Lymphoma FAQs
As more patients come forward with questions about the potential link between dupilumab (Dupixent®) and certain types of cancer, it’s important to separate facts from speculation. Our team at Morris James is actively investigating claims that Dupixent may increase the risk of cutaneous T-cell lymphoma (CTCL) and other serious conditions….By: Morris James LLP
-

Every Victory is a New Beginning: U.S. Supreme Court Agrees to Consider Freight Broker Liability
On Friday, October 3, 2025, the United States Supreme Court announced that it will provide vital guidance regarding the extent to which freight brokers are liable for alleged negligence in selecting motor carriers that transport goods for brokers’ customers….By: Benesch